TLIS Talis Biomedical
- 9.1500
- +0.1231+1.36%
- 9.3000
- +0.1500+1.64%
Talis Biomedical News
Talis Biomedical | 10-Q: Quarterly report
Talis Biomedical Secures Interim CFO Amidst Corporate Changes
Talis Biomedical Q4 EPS $(7.39) Up From $(15.15) YoY, Sales $195.00K Down From $257.00K YoY
Talis Biomedical (NASDAQ:TLIS) reported quarterly losses of $(7.39) per share. This is a 51.22 percent increase over losses of $(15.15) per share from the same period last year. The company reported
Talis Biomedical Ends Role of President Amid Reorganization
Why Talis Biomedical (TLIS) Stock Is Exploding Higher
Talis Biomedical Corp (NASDAQ:TLIS) shares are trading higher by 30% to $7.03 Tuesday morning after the company announced it is exploring strategic options to boost shareholder value due to current ma
Talis Reviewing Strategic Alternatives, Stock Rallies 35%
Azenta Reports Upbeat Earnings, Joins Talis Biomedical, Sally Beauty And Other Big Stocks Moving Higher On Tuesday
U.S. stocks traded higher, with the Dow Jones gaining around 500 points on Tuesday. Shares of Azenta, Inc. (NASDAQ:AZTA) rose on Tuesday after the company reported better-than-expected fourth-quarter
Talis Biomedical Jumps 30% As It Explores Strategic Alternatives, To Lay Off 90% Workforce
Cutera, Beyond Air Among Healthcare Movers
Talis Biomedical Shares Rise 28% in Premarket Trading on Job Cuts, Strategic Review
By Adriano Marchese Shares in Talis Biomedical jumped after its stock resumed trading in premarket on Tuesday after it said it will cut jobs and consider strategic alternatives for its business. At
Talis Biomedical: Alternatives Include Equity or Debt Financing, an Acquisition, Merger, Reverse Merger, Divestiture of Assets >TLIS
Talis Biomedical: Alternatives Include Equity or Debt Financing, an Acquisition, Merger, Reverse Merger, Divestiture of Assets >TLIS
Talis Biomedical Board Appointed Special Committee to Consider Wide Range of Strategic Alternatives >TLIS
Talis Biomedical Board Appointed Special Committee to Consider Wide Range of Strategic Alternatives >TLIS
Talis Biomedical Implementing Additional Cost-Saving Measures to Lower Cash Burn >TLIS
Talis Biomedical Implementing Additional Cost-Saving Measures to Lower Cash Burn >TLIS
Talis Biomedical Reducing Its Workforce by About 90 % >TLIS
Talis Biomedical Reducing Its Workforce by About 90 % >TLIS
Talis Biomedical Consolidating Ops to Single Site in Chicago >TLIS
Talis Biomedical Consolidating Ops to Single Site in Chicago >TLIS
Talis Biomedical 3Q Rev $140,000 >TLIS
Talis Biomedical 3Q Rev $140,000 >TLIS
Press Release: Talis Biomedical Announces Exploration of Strategic Alternatives and Cost Reduction Plan to Preserve Cash
Talis Biomedical Announces Exploration of Strategic Alternatives and Cost Reduction Plan to Preserve Cash REDWOOD CITY, Calif., Nov. 14, 2023 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation (Nasdaq:
Talis Biomedical Halted On Code News Pending
Talis Biomedical Halted On Code News Pending
Talis Biomedical Announces Exploration of Strategic Alternatives and Cost Reduction Plan to Preserve Cash
REDWOOD CITY, Calif., Nov. 14, 2023 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation (Nasdaq: TLIS), a diagnostic company dedicated to advancing health equity and outcomes through the delivery of ac
Stocks That Hit 52-Week Lows On Friday
Friday's session saw 169 companies set new 52-week lows. Points of Interest From Today's 52-Week Lows: Bristol-Myers Squibb (NYSE:BMY) was the largest firm by market cap to set a new 52-week low.Blu
Analysis
Price Target
No Data
